Related Experiment Video
Updated: Jun 20, 2026

A Pulmonary Trunk Banding Model of Pressure Overload Induced Right Ventricular Hypertrophy and Failure
Published on: November 29, 2018
Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy
Georgios K Efthimiadis1, Despina G Parcharidou, Georgios Giannakoulas
1First Cardiology Department, Cardiomyopathies Laboratory, Aristotle University of Thessaloniki Medical School, AHEPA Hospital, Thessaloniki, Greece. efthymos@med.auth.gr
Insights
Left ventricular outflow tract obstruction (LVOTO) at rest does not appear to be an independent risk factor for sudden death (SD) in hypertrophic cardiomyopathy patients. Other factors like syncope and wall thickness are more significant indicators for SD risk.
Area of Science:
- Cardiology
- Clinical Medicine
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease.
- Sudden death (SD) is a major concern in HCM patients.
- The role of left ventricular outflow tract obstruction (LVOTO) at rest in predicting SD in HCM remains controversial.
Purpose of the Study:
- To evaluate the potential of resting left ventricular outflow tract obstruction (LVOTO) as a novel risk factor for sudden death (SD) in patients with hypertrophic cardiomyopathy (HCM).
Main Methods:
- A cohort study involving 166 patients with HCM (112 men, mean age 51.8 years).
- Patients were assessed for peak instantaneous LVOTO gradients at rest (≥30 mm Hg).
- Follow-up median of 32.4 months for adverse cardiac events including SD, cardiac arrest, VT, or ICD discharge.
Main Results:
- 13 patients experienced adverse events during follow-up.
- Cumulative event-free survival was 92% in both LVOTO and non-LVOTO groups (p=NS).
- Resting LVOTO showed a low positive predictive value (8%) but high negative predictive value (92%) for SD. Syncope and maximal wall thickness ≥3 cm were significant risk factors for SD.
Conclusions:
- Resting left ventricular outflow tract obstruction (LVOTO) is not supported as an independent risk factor for sudden death (SD) in hypertrophic cardiomyopathy (HCM).
- Syncope and marked left ventricular hypertrophy (wall thickness ≥3 cm) are more significant predictors of SD in HCM patients.
- Further research may focus on combined risk stratification models for HCM.
Abstract:
The effect of left ventricular outflow tract obstruction (LVOTO) at rest on the incidence of sudden death (SD) in patients with hypertrophic cardiomyopathy is rather conflicting. The aim of this study was the evaluation of LVOTO at rest as a new potential risk factor for SD in hypertrophic cardiomyopathy. A total of 166 patients (112 men, 51.8 +/- 15.6 years) were studied; 50 patients (30.1%) had peak instantaneous LVOTO gradients of > or = 30 mm Hg at rest. During the follow-up period (median 32.4 months, range 1 to 209), 13 patients either died suddenly, or had cardiac arrest, documented sustained ventricular tachycardia, or implantable cardioverter defibrillator discharge. The cumulative event-free survival rate was 92% in patients with LVOTO, and 92% in patients without obstruction (p = NS). LVOTO at rest was associated with a particularly low positive predictive value for SD (8%), although a high negative predictive value (92%) was recorded. Patients having syncope or presenting with a maximum wall thickness > or =3 cm in echocardiography were more sensitive to SD emergence because they had a 13.07 (95% confidence interval 4.00 to 46.95, p <0.0001) and a 10.07 (95% confidence interval 2.92 to 34.79, p = 0.003) greater relative risk, respectively. In conclusion, our cohort study results do not support LVOTO as an independent risk factor for SD in patients with hypertrophic cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy V: Interprofessional Care

